For instance, the tumor driving BRAF(V600E) mutation, which is present in approximately 50% of human melanomas [4,5], suppresses mitochondrial oxidative phosphorylation and drives aerobic glycolysis through the activation of hypoxia inducible factor 1 subunit alpha [6,7]. Here, BRAF is linked to melanoma.